Abstract
No human studies exist on the use of recombinant human bone morphogenetic protein 2 (rhBMP-2) on an absorbable collagen sponge (ACS) as a sole graft material for lateral ridge augmentation in large ridge defect sites. This series evaluates the treatment outcome of maxillary anterior lateral ridge augmentation with rhBMP-2/ACS. Twenty patients were treated with rhBMP-2/ACS and fixation screws for space maintenance. Cone beam volumetric tomography measurements were used to determine gain in ridge width, and a bone core biopsy was obtained. The mean horizontal ridge gain was 1.2 mm across sites, and every site gained width.
Original language | English (US) |
---|---|
Pages (from-to) | 551-557 |
Number of pages | 7 |
Journal | The International journal of periodontics & restorative dentistry |
Volume | 34 |
Issue number | 4 |
DOIs | |
State | Published - Jul 1 2014 |
ASJC Scopus subject areas
- Medicine(all)